<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00495794</url>
  </required_header>
  <id_info>
    <org_study_id>SDP 06-128</org_study_id>
    <secondary_id>R18DK076622-01</secondary_id>
    <nct_id>NCT00495794</nct_id>
  </id_info>
  <brief_title>Adherence and Intensification of Medications (AIM) Implementation Study</brief_title>
  <official_title>Adherence and Intensification of Medications: A Population-Based Clinical Pharmacists Implementation Study Among Hypertensive Diabetes Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Good blood pressure (BP) control among patients with diabetes is essential in
      preventing diabetes complications and has been found to be not only cost-effective but
      cost-saving. Nonetheless, over 25% of VA patients with diabetes do not have adequate BP
      control. Among these poorly controlled patients, over 65% have problems with medication
      adherence or inadequate intensification of medications. We therefore propose a partnership
      with the VA Pharmacy Benefits Management (PBM) Office and VISN 11 to evaluate a tailored
      clinical pharmacist-based intervention to improve medication management, adherence and BP
      control.

      Objectives: The specific objectives of this implementation study are: 1) To evaluate the
      effects of the intervention on blood pressure (primary outcome) and glycemic and lipid
      control (secondary outcomes); 2) To assess the impact of the intervention on patients'
      adherence to blood pressure, anti-hyperglycemic, and lipid-lowering regimens, and intensity
      of these regimens; 3) To evaluate the cost-effectiveness of the intervention compared to
      usual care; 4) To evaluate the level of attainment of intervention implementation, examine
      the process of intervention implementation, and determine the potential for sustainability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Good blood pressure (BP) control among patients with diabetes is essential in
      preventing diabetes complications and has been found to be not only cost-effective but
      cost-saving. Nonetheless, over 25% of VA patients with diabetes do not have adequate BP
      control. Among these poorly controlled patients, over 65% have problems with medication
      adherence or inadequate intensification of medications. We therefore propose a partnership
      with the VA Pharmacy Benefits Management (PBM) Office and VISN 11 to evaluate a tailored
      clinical pharmacist-based intervention to improve medication management, adherence and BP
      control.

      Objectives: The specific objectives of this implementation study are: 1) To evaluate the
      effects of the intervention on blood pressure (primary outcome) and glycemic and lipid
      control (secondary outcomes); 2) To assess the impact of the intervention on patients'
      adherence to blood pressure, anti-hyperglycemic, and lipid-lowering regimens, and intensity
      of these regimens; 3) To evaluate the cost-effectiveness of the intervention compared to
      usual care; 4) To evaluate the level of attainment of intervention implementation, examine
      the process of intervention implementation, and determine the potential for sustainability.

      Methods: In this cluster randomized implementation trial, we will proactively identify, using
      clinical automated data, all diabetes patients within 3 VA sites who have poor blood pressure
      control and either poor refill adherence or insufficient medication intensification. (NIDDK
      R18 funds 2 non-VA sites.) Adherence and treatment intensification patterns will also be
      evaluated for glycemia and lipids if either of these risk factors is poorly controlled.
      Clinical pharmacists, trained in motivational interviewing techniques and guided by
      computerized adherence modules, will identify barriers to medication adherence and provide
      adherence counseling. They will also be authorized to change and titrate medications
      following site-specific algorithms. Patients in the non-intervention (control) teams will
      receive usual care. Blood pressure control and refill adherence will be assessed 6-months
      after the end of the intervention period. We will also conduct a formative evaluation during
      the course of the study and assess implementation attainment and potential for dissemination.

      Status: Data analysis complete. (Enrollment numbers are for VA and non-VA sites [control and
      intervention].)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Systolic Blood Pressure</measure>
    <time_frame>6 months prior to 6 months after the intervention period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>A1c Control</measure>
    <time_frame>12 months after intervention period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL Control</measure>
    <time_frame>12 months after invention period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4622</enrollment>
  <condition>Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Pharmacist management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Eligible patients receive usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinical pharmacist-based intervention</intervention_name>
    <description>Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
    <arm_group_label>Pharmacist management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        VA inclusion criteria

          1. Must be a veteran at a study site;

          2. Have a diagnosis of diabetes;

          3. Meet blood pressure, medication adherence and intensification requirements (as
             determined by the study team)

        Exclusion Criteria:

        VA Exclusion

          1. Dementia

          2. Traumatic brain injury

          3. Pregnancy

          4. Age &lt;18 or &gt;100
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M. E. Michele Heisler, MD MPA</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Ann Arbor Healthcare System, Ann Arbor, MI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Ann Arbor Healthcare System, Ann Arbor, MI</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Heisler M, Hofer TP, Klamerus ML, Schmittdiel J, Selby J, Hogan MM, Bosworth HB, Tremblay A, Kerr EA. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. Trials. 2010 Oct 12;11:95. doi: 10.1186/1745-6215-11-95.</citation>
    <PMID>20939913</PMID>
  </results_reference>
  <results_reference>
    <citation>Klamerus ML, Kerr EA, Bosworth HB, Schmittdiel JA, Heisler M. Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program. Chronic Illn. 2014 Mar;10(1):60-73. doi: 10.1177/1742395313496590. Epub 2013 Jul 26.</citation>
    <PMID>23892775</PMID>
  </results_reference>
  <results_reference>
    <citation>Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, Bermann M, Kerr EA. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012 Jun 12;125(23):2863-72. doi: 10.1161/CIRCULATIONAHA.111.089169. Epub 2012 May 8.</citation>
    <PMID>22570370</PMID>
  </results_reference>
  <results_reference>
    <citation>Meddings J, Kerr EA, Heisler M, Hofer TP. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Serv Res. 2012 Aug 21;12:270. doi: 10.1186/1472-6963-12-270.</citation>
    <PMID>22909303</PMID>
  </results_reference>
  <results_reference>
    <citation>Sussman JB, Zulman DM, Hayward R, Hofer TP, Kerr EA. Cardiac risk is not associated with hypertension treatment intensification. Am J Manag Care. 2012 Aug;18(8):414-20.</citation>
    <PMID>22928756</PMID>
  </results_reference>
  <results_reference>
    <citation>Selby JV, Schmittdiel JA, Fireman B, Jaffe M, Ransom LJ, Dyer W, Uratsu CS, Reed ME, Kerr EA, Hsu J. Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial. BMC Health Serv Res. 2012 Jul 2;12:183. doi: 10.1186/1472-6963-12-183.</citation>
    <PMID>22747998</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2007</study_first_submitted>
  <study_first_submitted_qc>July 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2007</study_first_posted>
  <results_first_submitted>September 3, 2014</results_first_submitted>
  <results_first_submitted_qc>September 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>hypertension</keyword>
  <keyword>adherence</keyword>
  <keyword>implementation</keyword>
  <keyword>medications</keyword>
  <keyword>organization of care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pharmacist Management</title>
          <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Eligible patients receive usual care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2319"/>
                <participants group_id="P2" count="2303"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1797"/>
                <participants group_id="P2" count="2303"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="522"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Pharmacist did not activate patient</title>
              <participants_list>
                <participants group_id="P1" count="522"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pharmacist Management</title>
          <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Eligible patients receive usual care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1797"/>
            <count group_id="B2" value="2303"/>
            <count group_id="B3" value="4100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.3" spread="11.7"/>
                    <measurement group_id="B2" value="65.3" spread="12.1"/>
                    <measurement group_id="B3" value="65.3" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="547"/>
                    <measurement group_id="B2" value="721"/>
                    <measurement group_id="B3" value="1268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1250"/>
                    <measurement group_id="B2" value="1582"/>
                    <measurement group_id="B3" value="2832"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1797"/>
                    <measurement group_id="B2" value="2303"/>
                    <measurement group_id="B3" value="4100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Systolic Blood Pressure</title>
        <time_frame>6 months prior to 6 months after the intervention period</time_frame>
        <population>intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Pharmacist Management</title>
            <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Eligible patients receive usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Systolic Blood Pressure</title>
          <population>intention to treat analysis</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1693"/>
                <count group_id="O2" value="2162"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.9" lower_limit="-9.5" upper_limit="-8.4"/>
                    <measurement group_id="O2" value="-9.0" lower_limit="-9.6" upper_limit="-8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A1c Control</title>
        <time_frame>12 months after intervention period</time_frame>
        <population>Includes only participants with an A1c in the 12 months after the intervention period.</population>
        <group_list>
          <group group_id="O1">
            <title>Pharmacist Management</title>
            <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Eligible patients receive usual care</description>
          </group>
        </group_list>
        <measure>
          <title>A1c Control</title>
          <population>Includes only participants with an A1c in the 12 months after the intervention period.</population>
          <units>percentage of total hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1477"/>
                <count group_id="O2" value="1920"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="1.4"/>
                    <measurement group_id="O2" value="7.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LDL Control</title>
        <time_frame>12 months after invention period</time_frame>
        <population>Includes only participants with a LDL in the 12 months after the intervention period.</population>
        <group_list>
          <group group_id="O1">
            <title>Pharmacist Management</title>
            <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Eligible patients receive usual care</description>
          </group>
        </group_list>
        <measure>
          <title>LDL Control</title>
          <population>Includes only participants with a LDL in the 12 months after the intervention period.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1410"/>
                <count group_id="O2" value="1824"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.1" spread="31.1"/>
                    <measurement group_id="O2" value="87.8" spread="32.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Pharmacist Management</title>
          <description>Eligible patients assigned to - adherence counseling and medication management delivered by a clinical pharmacist trained in behavioral counseling approaches (motivational interviewing)
Clinical pharmacist-based intervention: Pharmacist proactive outreach to patients systematically identified as having adherence or intensification problems; their use of tailored adherence counseling strategies; and their authorization to titrate medications according to prespecified algorithms</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Eligible patients receive usual care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2319"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2319"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>In the intervention arm, only 53% of subjects had a pharmacist encounter. Higher rates of participation might have led to a more substantial initial improvement and a detectable longer term effect.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Michele Heisler</name_or_title>
      <organization>VA Center for Clinical Management Research; University of Michigan</organization>
      <phone>734-845-3504</phone>
      <email>mheisler@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

